{"podcast":{"title":"Latent Space: The AI Engineer Podcast","slug":"latent-space-ai-engineer","podcast_index_feed_id":6058902,"rss_url":"https://api.substack.com/feed/podcast/1084089.rss","website_url":"https://www.latent.space/podcast","image_url":"https://substackcdn.com/feed/podcast/1084089/ca7468da5614a246d2906ee8926f6de7.jpg","author":"Latent.Space","episode_count":204,"summary":"The AI Engineer newsletter + Top technical AI podcast. How leading labs build Agents, Models, Infra, & AI for Science. See https://latent.space/about for highlights from Greg Brockman, Andrej Karpathy, George Hotz, Simon Willison, Soumith Chintala et al!","last_synced_at":null,"page_url":"https://stenobird.com/podcast/latent-space-ai-engineer"},"episode":{"title":"🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery","slug":"beyond-alphafold-how-boltz-is-open-sourcing-the-future-of-drug-discovery","published_at":"2026-02-12T02:12:14+00:00","page_url":"https://stenobird.com/podcast/latent-space-ai-engineer/beyond-alphafold-how-boltz-is-open-sourcing-the-future-of-drug-discovery","show_page_url":"https://stenobird.com/podcast/latent-space-ai-engineer","url":"https://www.latent.space/p/boltz","audio_url":"https://api.substack.com/feed/podcast/187696911/8242b1558c99b0e7e719726396b7f736.mp3","summary":"The next frontier in structural biology moves beyond predicting single protein chains to modeling complex molecular interactions and generative design. Boltz aims to democratize this frontier by providing open-source foundations and scalable infrastructure for drug discovery.","meta_description":"Explore the evolution from AlphaFold to Boltz-1 and Boltz-2, focusing on protein-ligand interactions, generative modeling, and open-source drug discovery.","key_points":["Main idea: Single-chain protein structure prediction is largely solved via evolutionary co-evolution data, shifting the focus to complex multi-chain interactions","Practical takeaway: Successful drug discovery requires moving from simple regression models to generative architectures capable of protein-ligand and protein-protein modeling","Failure mode: Relying solely on GitHub repositories is insufficient for widespread adoption; scientists need accessible, high-level interfaces like a 'cloud app' experience","Technical insight: The transition from AlphaFold 2 to newer models involves moving from predicting static structures to modeling dynamic interactions and affinity","Mission: Democratizing access to structural biology through open-source models paired with robust, user-friendly computational infrastructure"],"chapters":[{"start_ms":60000,"title":"The AlphaFold Moment","summary":"Reflecting on the impact of AlphaFold and the shift in structural biology from X-ray crystallography to computational prediction."},{"start_ms":415000,"title":"Beyond Single-Chain Proteins","summary":"Discussing the limitations of predicting single amino acid sequences and the need to model multi-chain complexes."},{"start_ms":1170000,"title":"Architectural Shifts in Modeling","summary":"The technical evolution from regression-based models to architectures capable of handling protein-small molecule and protein-RNA interactions."},{"start_ms":1555000,"title":"The Power of Recycling","summary":"How iterative feedback loops and recycling sequences within models refine structural accuracy."},{"start_ms":2270000,"title":"Democratizing Access via Infrastructure","summary":"Why providing a seamless product interface is as critical as the underlying open-source models for the scientific community."},{"start_ms":2630000,"title":"Boltz-2 and Affinity Prediction","summary":"Advancements in predicting the strength of molecular interactions and the move toward generative protein design."},{"start_ms":4140000,"title":"Validating Novel Designs","summary":"The challenge of validating models in de novo design spaces where no evolutionary co-evolution data exists."}],"topics":["Structural Biology","Protein Folding","Generative AI","Drug Discovery","Open Source Software","AlphaFold","Molecular Dynamics","Biotechnology"],"duration_seconds":4867,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/latent-space-ai-engineer/episodes/beyond-alphafold-how-boltz-is-open-sourcing-the-future-of-drug-discovery/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/latent-space-ai-engineer/beyond-alphafold-how-boltz-is-open-sourcing-the-future-of-drug-discovery.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}